Safety and Tolerability of Administering Leukemia-Specific Donor T Cells (mLSTs) after Allogeneic Transplant to Pediatric Patients with AML/MDS
- Resource Type
- Source
- Transplantation and Cellular Therapy. 28:S223
- Subject
Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology - Language
- ISSN
- 2666-6367